A mutation common in non-jewish Tay–Sachs disease: Frequency and RNA studies
B. R. Akerman
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
Search for more papers by this authorJ. Zielenski
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8
Search for more papers by this authorB. L. Triggs-Raine
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
Search for more papers by this authorE. M. Prence
E. K. Shriver Center for Mental Retardation, Waltham and the Harvard Medical School, Boston, Massachusetts 02115
Search for more papers by this authorM. R. Natowicz
E. K. Shriver Center for Mental Retardation, Waltham and the Harvard Medical School, Boston, Massachusetts 02115
Search for more papers by this authorJ. S. T. Lim-Steele
CA Tay-Sachs Disease Prevention Program, San Diego, California 92123
Search for more papers by this authorM. M. Kaback
CA Tay-Sachs Disease Prevention Program, San Diego, California 92123
Search for more papers by this authorE. H. Mules
Department of Molecular Biology and Biochemistry, Centre of Advanced Biotechnology and Medicine, Rutgers University, Tiscatawa, New Jersey 07102
Search for more papers by this authorG. H. Thomas
Genetics Laboratory, Kennedy Krieger Institute, Baltimore, Maryland 21223
Search for more papers by this authorJ. T. R. Clarke
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8
Search for more papers by this authorCorresponding Author
R. A. Gravel
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3Search for more papers by this authorB. R. Akerman
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
Search for more papers by this authorJ. Zielenski
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8
Search for more papers by this authorB. L. Triggs-Raine
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
Search for more papers by this authorE. M. Prence
E. K. Shriver Center for Mental Retardation, Waltham and the Harvard Medical School, Boston, Massachusetts 02115
Search for more papers by this authorM. R. Natowicz
E. K. Shriver Center for Mental Retardation, Waltham and the Harvard Medical School, Boston, Massachusetts 02115
Search for more papers by this authorJ. S. T. Lim-Steele
CA Tay-Sachs Disease Prevention Program, San Diego, California 92123
Search for more papers by this authorM. M. Kaback
CA Tay-Sachs Disease Prevention Program, San Diego, California 92123
Search for more papers by this authorE. H. Mules
Department of Molecular Biology and Biochemistry, Centre of Advanced Biotechnology and Medicine, Rutgers University, Tiscatawa, New Jersey 07102
Search for more papers by this authorG. H. Thomas
Genetics Laboratory, Kennedy Krieger Institute, Baltimore, Maryland 21223
Search for more papers by this authorJ. T. R. Clarke
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8
Search for more papers by this authorCorresponding Author
R. A. Gravel
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3
McGill University-Montreal Children's Hospital Research Institute, and the Department of Biology, McGill University, Montreal, Quebec, Canada, H3H 1P3Search for more papers by this authorAbstract
Tay-Sachs disease (TSD) is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the α-subunit of the lysosomal enzyme, β-N-acetylhexosaminidase A (Hex A). We have discovered that a Tay-Sachs mutation, IVS-9 + 1 G→A, first detected by Akli et al. (Genomics 11:124–134, 1991), is a common disease allele in non-Jewish Caucasians (10/58 alleles examined). A PCR-based diagnostic test, which detects an NlaIII site generated by the mutation, revealed a frequency among enzyme-defined carriers of 9/64 (14%). Most of those carrying the allele trace their origins to the United Kingdom, Ireland, or Western Europe. It was not identified among 12 Black American TSD alleles or in any of 18 Ashkenazi Jewish, enzyme-defined carriers who did not carry any of the mutations common to this population. No normally spliced RNA was detected in PCR products generated from reverse transcription of RNA carrying the IVS-9 mutation. Instead, the low levels of mRNA from this allele were comprised of aberrant species resulting from the use of either of two cryptic donor sites, one truncating exon 9 and the other within IVS-9, spliced to exon 10. Numerous additional splice products were detected, most involving skipping of one or more surrounding exons. Together with a recently identified allele responsible for Hex A pseudodeficiency (Triggs-Raine et al. Am J Hum Genet, 1992), these two alleles accounted for almost 50% (29/64) of TSD or carrier alleles ascertained by enzyme screening tests in non-Jewish Caucasians. © 1992 Wiley-Liss, Inc.
References
- Akli S, Chelly J, Lacorte J-M, Poenaru L, Kahn A (1991) Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11: 124–134.
- Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F (1977) Genetic variants of Tay-Sachs disease: Tay Sachs disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians and a Tay Sachs screening program in the French-Canadian population. Prog Clin Biol Res 18: 161–188.
- Barker D, Schafer M, White R (1984) Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36: 131–138.
- Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299.
- Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78: 151–155.
- Coulondre C, Miller JH, Farabaugh PJ, Gilbert W (1978) Molecular basis of base substitution hotspots in E. coli. Nature (London) 274: 775–780.
- Drucker L, Proia RL, Navon R (1992) Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population. Am J Hum Genet 51: 371–377.
- Fernandes M, Kaplan F, Natowicz M, Prence E, Kolodny E, Kaback MM, Hechtman P (1992) A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation. Hum Mol Genet, in press.
- Gravel RA, Triggs-Raine BL, Mahuran DJ (1991) Genetics and biochemistry of Tay-Sachs disease. Can J Neurol Sci 18: 419–423.
- Grebner EE, Tomczak J (1991) Distribution of three α-chain β-hexosaminidase A mutations among Tay-Sachs carriers. Am J Hum Genet 48: 604–607.
- Hechtman P, Boulay B, de Braekeleer M, Andermann E, Melançon S, Larochelle J, Prevost C, Kaplan F (1992) The intron 7 donor splice site transition: A second Tay-Sachs disease mutation in French-Canada. Hum Genet, in press.
- Hoar DI, Haslam DB, Starozik DM (1984) Improved direct molecular diagnosis and rapid fetal sexing. Prenat Diagn 4: 241–247.
- Koeberl DD, Bottema CDK, Buerstedde J-M, Sommer SS (1989) Functionally important regions of the factor IX gene had a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet 45: 448–457.
- Landels EC, Ellis IH, Fensom AH, Green PM, Bobrow M (1991) Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population. J Med Genet 28: 177–180.
- Landels EC, Green PM, Ellis IH, Fensom AH, Bobrow M (1992) β-Hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles. J Med Genet, in press.
- Lau MM, Neufeld EF (1989) A frameshift mutation in a patient with Tay-Sachs disease causes premature termination and defective intracellular transport of the alpha-subunit of beta-hexosaminidase. J Biol Chem 264: 21376–21380.
- McDowell GA, Mules EH, Fabacher P, Shapira E, Blitzer MG (1992) The presence of two different infantile Tay-Sachs disease mutations in a Cajun population. Am J Hum Genet, submitted.
- Mitsuo K, Nakano T, Kobayashi T, Goto I, Taniike M, Suzuki K (1990) Juvenile Sandhoff disease: a Japanese patient carrying a mutation identical to that found earlier in a Canadian patient. J Neurol Sci 98: 277–286.
- Mules EH, Hayflick S, Miller CS, Reynolds LW, Thomas GH (1992) Six novel deleterious and three neutral mutations in the gene encoding the α-subunit of hexosaminidase A in non-Jewish individuals. Am J Hum Genet 50: 834–841.
- Mules EH, Hayflick S, Dowling CE, Kally TE, Akerman BR, Gravel RA, Thomas GH (1992) Molecular basis of hexosaminidase A deficiency and pseudo-deficiency in the Berks County Pennsylvania Dutch. Hum Mutat, submitted.
- Myerowitz R, Costigan FC (1988) The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the α-chain of β-hexosaminidase. J Biol Chem 263: 18567–18569.
- Myerowitz R, Hogikyan ND (1987) A deletion involving Alu sequences in the β-hexosaminidase α-chain of French-Canadians with Tay-Sachs disease. J Biol Chem 262: 15396–15399.
- Navon R, Proia RL (1989) The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 243: 1471–1474.
- Navon R, Proia RL (1991) Tay-Sachs disease in Moroccan Jews: Deletion of a phenylalanine in the α-subunit of β-hexosaminidase. Am J Hum Genet 48: 412–419.
- Neufeld EF (1989) Natural history and inherited disorders of a lysosomal enzyme, β-hexosaminidase. J Biol Chem 264: 10927–10930.
- Ohno K, Suzuki S (1988) Mutation in Gm2-gangliosidosis B1 variant. J Neurochem 50: 316–318.
- Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879.
- Paw BH, Kaback MM, Neufeld EF (1989) Molecular basis of adultonset and chronic GM2 gangliosidosis in patients of Ashkenazi Jewish origin: Substitution of serine for glycine at position 269 of the α-subunit of β-hexosaminidase. Proc Natl Acad Sci USA 86: 2413–2417.
- Paw BH, Tieu PT, Kaback MM, Lim J, Neufeld EF (1990) Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program. Am J Hum Genet 47: 698–705.
- Paw BH, Wood LC, Neufeld EF (1991) A third mutation at the CpG dinucleotide of codon 504 and a silent mutation at codon 506 of the HEXA gene. Am J Hum Genet 48: 1139–1146.
-
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
Molecular Cloning: A Laboratory Manual,
2nd ed.
Cold Spring Harbor, NY:
Cold Spring Harbor Laboratory.
10.1111/j.1095-8312.1996.tb01434.x Google Scholar
- Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2 gangliosidosis. In CR Scriver, AL Beaudet, WS Sly, D Valle (eds): The Metabolic Basis of Inherited Disease, 6th ed, Vol. 2. New York: McGraw-Hill, pp 1807–1839.
- Senapathy P, Shapiro MB, Harris NL (1990) Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project. Methods Enzymol 183: 252–278.
- Triggs-Raine BL, Feigenbaum ASJ, Natowicz M, Skomorowski M-A, Schuster SM, Clarke JTR, Mahuran DJ, et al. (1990) Screening for carriers of Tay-Sachs disease among Ashkenazi Jews—a comparison of DNA-based and enzyme-based tests. N Engl J Med 323: 6–12.
- Triggs-Raine BL, Akerman BR, Clarke JTR, Gravel RA (1991) Sequence of DNA flanking the exons of the HEXA gene and identification of mutations in Tay-Sachs disease. Am J Hum Genet 49: 1041–1054.
- Triggs-Raine BL, Mules EH, Kaback MM, Lim-Steele JST, Dowling CE, Akerman BR, Natowicz MR, Grebner EE, Navon R, Welch JP, Greenberg CR, Thomas GH, Gravel RA (1992) A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: Implications for carrier screening. Am J Hum Genet 51: 793–801.
- Vecht J, Zeigler M, Segal M, Bach G (1983) Tay-Sachs disease among Moroccan Jews. Isr Med Sci 19: 67–69.
- Winship PR (1989) An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucl Acids Res 17: 1266.